Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA 403 Forbidden error page is now shown, replacing the study record content with the site chrome. This indicates access to the page is blocked rather than a content update to the study record.SummaryDifference22%

- Check45 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a new site revision tag used for page versioning.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend update to the page. No substantive content related to the study details appears to be changed.SummaryDifference0.0%

- Check82 days agoChange DetectedThe sponsor listing changed from Gossamer Bio Inc. to Gossamer Bio USA, Inc., and the page revision moved from v3.6.3 to v3.6.4, indicating administrative updates to the study record.SummaryDifference0.1%

- Check103 days agoChange DetectedRevision: v3.6.3 update has replaced v3.6.2 on the page, signaling a new software build for the site. This is a software build update and does not indicate changes to the study content or page data.SummaryDifference0.0%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.